2019 American Transplant Congress
Utilization of DCD Donors >50 Years Old for Liver Transplantation
Arizona Transplant Associates, PC, Phoenix, AZ
*Purpose: End stage liver disease is becoming more prevalent in the United States with approximately 4.9 million adults carrying the diagnosis. It is estimated that…2019 American Transplant Congress
Incidence and Risks for Non-alcoholic Fatty Liver Disease and Steatohepatitis Post Liver Transplant: Systematic Reveiw and Meta-Analysis
1Beaumont Hospital, Ann Arbor, MI, 2University of Michigan, Ann Arbor, MI
*Purpose: Recurrent and denovo non-alcoholic fatty liver (NAFLD) and non-alcoholic steatohepatitis (NASH) are important post-liver transplant (LT) outcomes given risk to graft viability. The true…2019 American Transplant Congress
Early Allograft Dysfunction in the Setting of Histologic Ischemia Reperfusion Injury Following Liver Transplantation: Analysis of Predictors and Outcomes
Department of Surgery, The Dumont-UCLA Transplant Center, Los Angeles, CA
*Purpose: Hepatic ischemia-reperfusion injury (IRI) in Liver Transplantation (LT) is believed to contribute to Early Allograft Dysfunction (EAD). However, the relationship between IRI and EAD…2019 American Transplant Congress
CEACAM1 – p38 Signaling Axis Alleviates Peri-Transplant Liver Injury: From Mouse-to-Human
1UCLA, Los Angeles, CA, 2City of Hope, Duarte, CA
*Purpose: Although CEACAM1 (CM1; carcinoembryonic antigen-related cell adhesion molecule 1; CD66a) regulates hepatic metabolism, its role in orthotopic liver transplantation (OLT) is unknown. A recent…2019 American Transplant Congress
The Experience of Somatostatin to Prevent Small-for-Size Syndrome in Patients with Small Graft in Living Donor Liver Transplantation
Korea University College of Medicine, Seoul, Korea, Republic of
*Purpose: The small-for-size syndrome has to be overcome especially in living donor liver transplantation (LDLT) considering the graft and patient survival and morbidities. We introduce…2019 American Transplant Congress
Not for the Faint of Heart: The Impact of Post-Reperfusion Syndrome during Liver Transplantation Using Livers with Significant Macrosteatosis
*Purpose: The present study represents the largest series of donor livers with moderate macrosteatosis and provides detailed analysis of the effects of post reperfusion syndrome…2019 American Transplant Congress
Inferior Graft and Patient Survival Following Offspring to Parent Living Donor Liver Transplantation
Transplant Surgery, University of Colorado, Aurora, CO
*Purpose: Offspring (donor) to parent (recipient) transplant is the most common form of living donor liver transplant in the United States. Following living donor kidney…2019 American Transplant Congress
Reduction in Waitlist Time Using HCV Positive Liver Grafts in HCV Negative Recipients
Ochsner Health System, New Orleans, LA
*Purpose: With direct-acting antiviral (DAA) therapy, we feel that HCV+ organs are safe for all patients regardless of their HCV status and have adopted a…2019 American Transplant Congress
Pulmonary Complications in Living Liver Donors
*Purpose: Due to the shortage of deceased donors, living donor liver transplantation has been the main treatment option for the end - stage liver disease.…2019 American Transplant Congress
A Comparison of the BAR, DRM, DRI, sRRI, ET-DRI, D-MELD and SOFT Score to Predict Outcome after Liver Transplantation in the SRTR Database
*Purpose: Several risk models have been developed to predict outcome after liver transplantation (LT) in the last decade. This study analyzes the ability of these…
- « Previous Page
- 1
- …
- 7
- 8
- 9
- 10
- 11
- …
- 20
- Next Page »